Country | : Germany ![]() |
Sector | : Pharma / Big Pharma |
Market Cap | : 76,130 (M€) |
Score (0-10) | Sector avg | Ranking out of 544 | |||
---|---|---|---|---|---|
Sustainability | 2.7 | 5.7 | 537 | ||
Our approach is based on analytical items contributing to the E, the S and the G, that can be highlighted as sustainability precursors and can be combined in an intellectually acceptable way. | |||||
Governance | 3.0 | 6.1 | 546 | ||
Board independence? | Yes | ||||
Splitting CEO and chairman roles? | No | ||||
+10 other Governance metrics | |||||
Social | 6.7 | 6.9 | 212 | ||
Are accident at work declining? | Yes | ||||
Wage dispersion trend vs peers | 6 / 10 | ||||
+22 other Social metrics | |||||
Environment | 4.4 | 6.4 | 366 | ||
Emission or consumption per € of capital employed on :
► Energy ► CO2 emissions ► Waste ► Water withdrawal |
|||||
ESG impact on target price | -6.2% |
0.7% | 538 |
Company | Sustainability | Ranking |
---|---|---|
![]() |
7.3 | 40 |
![]() |
3.7 | 473 |
![]() |
6.0 | 171 |
![]() |
2.7 | 537 |
![]() |
7.0 | 62 |
![]() |
6.4 | 122 |
![]() |
6.6 | 94 |
![]() |
6.2 | 137 |
Learn more on our methodology : | |
Access for issuers : | |
To AlphaValue research platform: |